Disclosure of payments made to HCPs and HCOs in the UK

Disclosure of payments made to HCPs and HCOs in the UK

ALK-Abelló Ltd is committed to greater transparency of financial relationships with healthcare professionals and healthcare organisations. Alongside other ABPI member companies, ALK-Abelló Ltd discloses all transfers of value made to healthcare professionals and healthcare organisations. This is in line with the ABPI Code of Practice as well as the EFPIA Disclosure Code, which has been adopted across 33 European countries. This disclosure is made annually on the ABPI website, Disclosure UK.

Our payments made to HCPs and HCOs in the UK in 2020

In 2020 ALK-Abelló Ltd paid a total of £29,261.86 to support 43 UK HCP’s to attend scientific conferences and meetings, to speak at ALK-Abelló meetings and to provide various consultancy services. Disclosure at an individual level is voluntary. Where consent has not been obtained to disclose on a named basis the total amount is shown in aggregate.

In addition to the transfers of value stated above, £29,328.85 was paid to HCPs and HCOs for costs directly associated with research and development.

ALK-Abelló Ltd also paid a total of £13,890 to HCO’s in sponsorships and grants, details of individual payments to HCO’s can be also be found in the link above.

Financial Support Given to Patient Organisations and Charities

Payments made to patient organisations and charities are not required to be disclosed as part of the ABPI disclosure process and are therefore listed publicly below:

In 2020 ALK UK Ltd gave financial support to the following patient organisations & charities:

Anaphylaxis Campaign £39,190

Educational support to help raise awareness of the signs, symptoms and treatment options for patients at risk of anaphylaxis.

Allergy UK £38,500

Educational support to help raise awareness of the signs, symptoms and treatment options for patients with allergic disease and patients at risk of anaphylaxis.

Last updated: 2021.05.27